BANK OF AMERICA CORP /DE/ - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$72,909,000
-37.3%
421,907
-58.3%
0.02%
-40.5%
Q4 2014$116,315,000
+38.0%
1,011,966
+87.5%
0.04%
+55.6%
Q3 2014$84,307,000
-8.9%
539,596
-28.1%
0.03%
-10.0%
Q2 2014$92,541,000
-21.1%
750,235
-33.7%
0.03%
-31.8%
Q1 2014$117,220,000
+10.2%
1,131,363
-4.3%
0.04%
+12.8%
Q4 2013$106,346,000
-44.4%
1,182,406
-58.7%
0.04%
-48.0%
Q3 2013$191,346,000
-4.5%
2,861,026
-5.6%
0.08%
-10.7%
Q2 2013$200,444,0003,030,1170.08%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders